Yuki Sato

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 3

Top Topics

Atrial Fibrillation

Stem Cell Transplantation

Health Insurance

Electronic Health Record

Top Venues

Expert opinion on drug safety

British journal of clinical pharmacology

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Shungo Imai, Hitoshi Kashiwagi, Yuki Sato, Takayuki Miyai, Mitsuru Sugawara, Yoh Takekuma
Factors affecting creatine phosphokinase elevation during daptomycin therapy using a combination of machine learning and conventional methods. British journal of clinical pharmacology (2021)
Shungo Imai, Kenji Momo, Hitoshi Kashiwagi, Yuki Sato, Takayuki Miyai, Mitsuru Sugawara, Yoh Takekuma
A cross-sectional survey of hospitalization and blood tests implementation status in patients who received tolvaptan under 75 years of age using a Japanese claims database. Expert opinion on drug safety 20 (10) (2021)
Shota Kadomura, Shungo Imai, Kenji Momo, Yuki Sato, Hitoshi Kashiwagi, Tatsuya Itoh, Mitsuru Sugawara, Yoh Takekuma
Effects of piperacillin/tazobactam or cefepime on folinate dose in patients receiving high-dose methotrexate: A retrospective cohort study using Japanese administrative claims data. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)